National Vision (NASDAQ:EYE) Price Target Cut to $39.00 by Analysts at Citigroup

National Vision (NASDAQ:EYE) had its price target trimmed by Citigroup from $40.00 to $39.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other brokerages also recently issued reports on EYE. Jefferies Financial Group reaffirmed a “buy” rating and issued a $40.00 price target on shares of National Vision in a report on Thursday, March 5th. Morgan Stanley reduced their price target on shares of National Vision from $30.00 to $22.00 and set an “equal weight” rating on the stock in a report on Thursday. Wells Fargo & Company reduced their price target on shares of National Vision from $30.00 to $20.00 and set an “equal weight” rating on the stock in a report on Thursday. Wall Street Zen downgraded shares of National Vision from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Finally, Roth Mkm set a $25.00 price target on shares of National Vision in a report on Thursday. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, National Vision currently has an average rating of “Moderate Buy” and a consensus price target of $29.23.

National Vision Stock Down 1.5%

Shares of NASDAQ EYE opened at $17.45 on Friday. National Vision has a 12-month low of $14.75 and a 12-month high of $30.02. The company has a market capitalization of $1.40 billion, a PE ratio of 30.61, a price-to-earnings-growth ratio of 1.36 and a beta of 1.18. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.62 and a quick ratio of 0.33. The firm’s 50-day moving average is $24.84 and its two-hundred day moving average is $26.30.

National Vision (NASDAQ:EYE) last announced its quarterly earnings results on Wednesday, May 13th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. National Vision had a net margin of 2.31% and a return on equity of 6.41%. The company had revenue of $543.88 million for the quarter, compared to the consensus estimate of $545.09 million. During the same quarter in the prior year, the firm earned $0.34 earnings per share. The company’s revenue for the quarter was up 6.6% compared to the same quarter last year. National Vision has set its FY 2026 guidance at 0.850-1.090 EPS. Equities analysts anticipate that National Vision will post 0.66 EPS for the current fiscal year.

Insider Activity

In related news, Chairman L Reade Fahs sold 7,601 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $29.58, for a total value of $224,837.58. Following the sale, the chairman directly owned 694,880 shares of the company’s stock, valued at approximately $20,554,550.40. This trade represents a 1.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.40% of the company’s stock.

Hedge Funds Weigh In On National Vision

Several institutional investors and hedge funds have recently bought and sold shares of EYE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in National Vision by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company’s stock worth $591,000 after purchasing an additional 1,948 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in National Vision by 6.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 235,125 shares of the company’s stock worth $3,005,000 after purchasing an additional 13,384 shares during the last quarter. Creative Planning acquired a new position in National Vision during the second quarter worth approximately $395,000. Walleye Capital LLC increased its position in National Vision by 29.4% during the second quarter. Walleye Capital LLC now owns 27,127 shares of the company’s stock worth $624,000 after purchasing an additional 6,170 shares during the last quarter. Finally, Cerity Partners LLC increased its position in National Vision by 13.8% during the second quarter. Cerity Partners LLC now owns 16,887 shares of the company’s stock worth $389,000 after purchasing an additional 2,049 shares during the last quarter.

Key National Vision News

Here are the key news stories impacting National Vision this week:

• Positive Sentiment: National Vision reported first-quarter earnings and revenue that beat estimates, with same-store sales up 4.5% and operating margin expanding by 320 basis points, reinforcing the view that its turnaround is gaining traction. Article Title
• Positive Sentiment: The company reiterated its 2026 guidance, suggesting management remains confident in its outlook despite a mixed revenue print and ongoing macro pressure. Article Title
• Neutral Sentiment: Citigroup lowered its price target to $39 from $40 while keeping a buy rating, and other firms also trimmed targets, including Wells Fargo to $20 and Bank of America to $30; the cuts were notable, but all implied meaningful upside from the current share price. Article Title
• Negative Sentiment: A securities-law investigation announced by Johnson Fistel could create some overhang on the stock if investor concerns or legal risk intensify. Article Title

About National Vision

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price?conscious consumer segments.

Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.